Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on PARTNERSHIP ASSURANCE GROUP. We currently have 7 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
PARTNERSHIP ASSURANCE GROUP
PARTNERSHIP ASSURANCE GROUP
Panmure Morning Note 11-3-2016
11 Mar 16
Following the announcement yesterday that the merger with Just Retirement had received regulatory approval we anticipate relatively little interest in the figures today and much more on the outlook for the merged entity. The merger is due to complete in early April now. For the record, the headline IFRS Operating profit at £40m (-37.5%) compared to our consensus at £43m with the slight miss due to some non-recurring assumption changes that have impacted the in force profit. The final dividend of will be based on the Just Retirement final dividend of 1.1p/share adjusted for the merger thus making 0.92p/share for Partnership shareholders or 1.42p for the full year (2014: 1.5p). The Embedded Value (MCEV) NAV at 31 Dec was flat at 144p (31 Dec 2014: 144p) per share lower than our 154p per share forecast partly reflecting lower profitability that we had anticipated. The Solvency II coverage ratio was 144% better than we believe many will have anticipated, with an economic surplus of £178m. Slightly disappointing figures but largely irrelevant given the merger.
Panmure Research - Partnership Assurance Flash 23-11-15
23 Nov 15
Just Retirement and Partnership have announced a delay to their planned nuptials. Just Retirement intends to delay the posting of the shareholder circular until the regulator (the PRA) has commented on its internal model, along with all the other insurers, in early December. Whilst it will only postpone the anticipated completion date a few weeks from late December into January we think it is disappointing given that the PRA timescale has been known about for many months. Separately following the detailed full year sales guidance provided by Partnership we are cutting our 2015F full year sales forecast from £602m to £558m which has led us to cut our 2015F IFRS Operating EPS to 9.6p/share from 10.8p/share previously. The valuation remains highly attractive with the share price at a 13% discount to our forecast Embedded Value at 31 Dec 2015 of 154p/share.
Panmure Morning Note 20-11-15
20 Nov 15
Partnership has announced the name of its partner in the US to launch a medically underwritten immediate annuity comparable to Partnership's UK Care annuity. It is Genworth, the market leader in Long Term Care (LTC) with c25% of the US LTC in force policies. Genworth will bring brand, market leading expertise, an existing operating platform and distribution in the US. We are not adjusting our forecasts at this stage but believe that this is very positive for the longer term outlook of Partnership/JRP post the merger with Just Retirement. The product will be launched in Q1 2016. The valuation remains compelling on both Partnership and Just Retirement and we consequently maintain our Buy recommendation and 165p/share target price.
Panmure Morning Note 05-11-15
05 Nov 15
Partnership has delivered a solid sales performance with sales at £109m (+22%) in Q3 following the introduction of the pension changes in April with good guidance for H2 (+10% on H1) and still on track to deliver £200m of Bulk sales (£92m at 9M stage with a further £60m of ‘exclusives'). Total sales in Q3 at £109m (+22%) was largely in line with consensus at £119m but below our £153m forecast reflecting lower hard to forecast Bulk sales at £24m (Q3 2014: £nil). The Bulk sales at £24m compared to our £60m forecast and consensus at £30m. Individual annuity sales at £68m (flat) compared to our £77m forecast and consensus at £73m. Following the share price fall we have upgraded our recommendation to Buy from Hold and note that the shares are now trading at a 10% discount to 30 June EV of 147p/share. In our view the shares should be trading at a premium rather than a discount to EV given the value of its new business. Buy. We anticipate that the proposed merger with Just Retirement will complete by 2015 year end.
Panmure Morning Note 11-08-15
11 Aug 15
We are surprised by today's announcement that Partnership and Just Retirement are to merge. It's an all share agreed merger whereby each PA share will be exchanged for 0.834 new shares in Just Retirement. In effect this equates to PA being taken out at c166p per share, although we think JR's share price will be under pressure today. The top jobs (CEO and FD) have been retained by JR's management team with PA's CEO Steve Groves stepping down. There are expected to be cost synergies of c£40m pa and the cost of achieving this is c£60m. Lastly there will be an equity raise of £150m. We are slightly sceptical of the reasons for the merger (Synergies, BPA scale etc) and take PA to a Hold recommendation and lower our target price to 165p per share from 175p previously.
Panmure Research - UK Insurance 27-07-15
27 Jul 15
Following a strong performance in 2012/13/14 and Q1 2015 the insurance sector has traded sideways in Q2 reflecting difficult investment markets, tough trading conditions and uncertainty ahead of the introduction of Solvency II. We believe that Solvency II will have a relatively muted impact on the sector and welcome its introduction if only so that the debate can move on. We are not anticipating any major surprises with the interim results that kick off on Tuesday 28th July with Jardine Lloyd Thompson. In our view the three main areas of interest will be 1) the potential impact of Solvency II on all insurers 2) impact of changes to the individual annuity market 3) recent management changes in the sector.
VPC Speciality Lending Investments PLC – sticking to your knitting pays dividends
05 Dec 16
A 25% discount on a dividend paying vehicle suggests either (a) lack of belief in the NAV, (b) lack of belief in the dividend, (c) concerns over future delivery, (d) a shareholder’s base not normally exposure to “closed end structures” or (e) some combination of (a) to (d). We had a first meeting with the management team and London representative of VPC Speciality Lending to try to better understand why the share price had fallen quite so much.
N+1 Singer - Grainger - Final results in line, further progress on PRS investment pipeline
01 Dec 16
Grainger has reported FY16 final results this morning with key NNNAV and recurring PBT metrics in line with our forecasts. Sales performance and rental income growth was strong in H2, as previewed in the positive FY trading update driving our 19% PBT upgrade in early October (11/10). The PRS investment pipeline continues to grow now standing at £389m secured and £347m in legals as Grainger pursues an £850m investment target by 2020. A 3.05p final dividend is in line with the revised policy to distribute 50% net rental income. The shares continue to trade on a significant, and unwarranted, 20%+ discount to NNNAV. We reiterate our BUY recommendation.
Better Capital – A tale of two funds
05 Dec 16
Our gut feel on the results is that BCAP’s Gardner disposal feels viable (albeit as a late Q1 transaction). Post Gardner, the exit profile for BCAP’s portfolio is slanted towards the years 2018/19 and not earlier; we view the market’s current pricing as cautious (14% disc to our estimate of FV). In contrast, BC12’s more consumer facing portfolio remains a work in progress and may well offer further disappointment before turning a corner; the market valuation (51% discount to NAV) is cautious but probably fair given the difficulties.
Meeting near-term headwinds
06 Dec 16
In its trading update IFG reported that performance has been in line with management expectations. The cooling effect of market uncertainty on growth in James Hay and financial advice client numbers, together with the impact of low interest rates, remain a near-term head wind for revenues. Even so, with Saunderson House continuing to increase profits, IFG expects to match 2015 earnings. The long-term growth opportunity presented by an ageing population and pension freedoms remains in place and to address this IFG is continuing investment to enhance its service and increase operational gearing.
Small Cap Breakfast
07 Dec 16
Creo Medical group—Schedule 1 update.. £20m raise. Expected market cap £61.2m, admission expected 9 December. ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m. RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m
05 Dec 16
As we mentioned in our 18 November 2016 note, a continuation vote was expected to be announced before the end of 2016. The announcement last Friday included details of the continuation vote, and in particular, a recommendation by the Directors to replace the June 2015 strategy of selling non-core assets and developing the core projects, with a new strategy of an orderly sale of the Company’s assets, with a target of selling all assets by 31 December 2019 and a distribution policy for returning monies to shareholders following disposals. Alongside these recommendations, there are proposed changes to the remuneration for the investment manager.